Catalyst Pharmaceuticals, Inc. (CPRX)
NASDAQ: CPRX · Real-Time Price · USD
20.97
-0.18 (-0.83%)
Nov 21, 2024, 10:59 AM EST - Market open
Catalyst Pharmaceuticals Employees
Catalyst Pharmaceuticals had 167 employees as of December 31, 2023. The number of employees increased by 85 or 103.66% compared to the previous year.
Employees
167
Change (1Y)
85
Growth (1Y)
103.66%
Revenue / Employee
$2,757,377
Profits / Employee
$855,072
Market Cap
2.50B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
QuidelOrtho | 7,100 |
Zai Lab | 2,175 |
Privia Health Group | 1,102 |
Twist Bioscience | 919 |
TransMedics Group | 584 |
Iovance Biotherapeutics | 557 |
Protagonist Therapeutics | 112 |
Apogee Therapeutics | 91 |
CPRX News
- 2 days ago - Catalyst Pharmaceuticals to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 8 days ago - Catalyst Pharmaceuticals Recognized Among BioSpace 2025 Best Places to Work - GlobeNewsWire
- 14 days ago - Catalyst Pharmaceuticals, Inc. (CPRX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 14 days ago - Catalyst Pharmaceuticals Reports Strong Third Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 4 weeks ago - Catalyst Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 6, 2024 - GlobeNewsWire
- 6 weeks ago - Catalyst Pharmaceuticals Donates $100,000 to the American Red Cross Hurricane Helene Relief Efforts - GlobeNewsWire
- 7 weeks ago - Catalyst Pharmaceuticals to Participate in the BofA Securities CNS Therapeutics Virtual Conference 2024 - GlobeNewsWire
- 2 months ago - Catalyst Pharmaceuticals Announces Sub-Licensee DyDo Pharma Received Approval to Commercialize FIRDAPSE® in Japan - GlobeNewsWire